Phase II exploratory study of brostallicin PNU-166196A as third/fourth line chemoterapy in adult patients with advanced/metastatic colorectal cancer CRC .

ABSTRACT:

DISEASE(S): Use For The Treatment Of Advanced/metastatic Colorectal Cancer, As Third/fourth Line Chemioterapy.

PROVIDER: 2518268 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR